技术与痴呆症 会议前会议
1Ontario Brain Institute, Toronto, ON, Canada.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 23, 2025
概括
对于老年痴呆症患者来说,可穿戴技术的采用是有限的. 科特克斯计划使社区团体能够测试和扩展神经技术,改善痴呆症护理和结果.
科学领域:
- 神经技术的神经技术
- 老年学是指老年学的学科.
- 数字健康数字健康
背景情况:
- 对于患有轻度认知障碍 (MCI),阿尔茨海默病和相关痴呆症 (ADRD) 的老年人,广泛采用可穿戴技术仍然是一个挑战.
- 这限制了可穿戴设备改变痴呆症护理和改善患者治疗结果的潜力.
- 安大略大脑研究所开发了CORTEX计划,以解决这个差距.
研究的目的:
- 分享从共同设计和启动CORTEX计划中学到的经验教训.
- 展示社区参与如何促进可穿戴技术的测试,实施和扩展.
- 概述加拿大痴呆症注册表的发展作为一个旗舰倡议.
主要方法:
- 与社区团体和有实践经验的个人共同设计CORTEX计划.
- 与患者组合作进行初步试点研究.
- 利用学习成果,与安大略省阿尔茨海默病学会合作推出加拿大痴呆症注册表.
主要成果:
- 科雷克斯计划使社区团体能够测试和扩展神经技术.
- 加拿大痴呆症登记 facilitates 了解早期痴呆的旅程和诊断.
- 神经技术正在与临床相关的尺度对不同人群进行测试.
结论:
- 像CORTEX这样的社区主导的倡议对于在痴呆症护理中采用可穿戴技术至关重要.
- 加拿大痴呆症注册会加强早期检测,并将神经技术整合到社区护理途径中.
- 这种方法旨在改善痴呆症患者获得及时和适当护理的机会.
相关概念视频
01:30Dementia
482
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
482
01:22Alzheimer's Disease: Treatment
744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
01:15Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K